Pyxis Oncology Inc.

1.20
0.07 (6.19%)
At close: Feb 28, 2025, 3:59 PM
1.19
-0.83%
After-hours: Feb 28, 2025, 05:03 PM EST

Pyxis Oncology Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 2M 1.84M 1.25M 444K n/a
Gross Profit -2M -1.84M -1.25M -444K n/a
Operating Income -82.2M -123.48M -69.72M -12.89M -2.88M
Interest Income 6.63M 2.76M 23K 66K 107K
Pretax Income -73.79M -120.72M -75.97M -12.83M -2.77M
Net Income -73.79M -117.95M -81.54M -12.76M -2.67M
Selling & General & Admin 32.61M 37.35M 18.66M 3.85M 1.66M
Research & Development 47.89M 86.13M 51.05M 9.05M 1.22M
Other Expenses n/a n/a 181K n/a n/a
Operating Expenses 82.2M 123.48M 69.72M 12.89M 2.88M
Interest Expense n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 82.2M 123.48M 69.72M 12.89M 2.88M
Income Tax n/a -2.76M 5.56M -66K -107K
Shares Outstanding (Basic) 39.9M 33.03M 32.22M 34.31M 34.31M
Shares Outstanding (Diluted) 39.9M 33.03M 32.22M 34.31M 34.31M
EPS (Basic) -1.85 -3.57 -2.53 -0.37 -0.08
EPS (Diluted) -1.85 -3.57 -2.53 -0.37 -0.08
EBITDA -78.49M -122.77M -69.07M -12.43M n/a
Depreciation & Amortization 2M 1.84M 1.25M 444K 2.88M